One of the fighters against COVID-19 Capricor Therapeutics has rising stock which could reach $10 soon as more investors having intentions to buy healthcare and pharmaceutical stocks. Dozens of such stocks are increasing since the outbreak. After they find the cure more and more will buy their shares to get a quick ROI. CAPR’s scenario would repeat the same. Most of the global funds are concentrated around the pandemic and directly involved corporations’ shares will have positive price changes.
In 2019 Capricor Therapeutics’ equity had been rising along with total assets. Q4 2019 reports show double times positive change in assets and equities. However, the earnings had been negative in all quarter fiscal reports.
Editor in Chief.
Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life